CDK4/6 inhibitors change landscape of breast cancer treatment: 2 studies Presented ByProf. Dennis Slamon, Prof. George Sledge, Prof. Nadia Harbeck TrialMonaleesa-3, Monarch 2 ConferenceESMO 2019 TypePeer-reviewed article 26 November 2019 22:03